Missouri Biotechnology Association Board of Directors - 2011

Mitchell Seyedin

Mitchell Seyedin, Ph.D., joined ISTO in September 2003. Before joining ISTO Technologies, Dr. Seyedin served as President and CEO of CBYON Inc., which developed and marketed advanced image-guided surgical systems. In 1995, he founded Orquest, an orthobiologic company that developed biological products for orthopedic applications. He served as its CEO for the first two years, as its Chairman until October 2001, and as a Board member until its acquisition by Johnson & Johnson in January 2003. In 1990, Dr. Seyedin co-founded Metra Biosystems and served as Vice President of Research & Development. Metra developed and commercialized diagnostic tests for osteoporosis and cancer. In 1995, Metra went public and was later acquired by Quidel (NASDAQ:QDEL) in June 1999. Before founding Metra, Dr. Seyedin was the Director of Research at Collagen Corporation, where he was responsible for bone and cartilage research. Currently, he serves on the Board of Directors of BioSet Inc., a privately held biotechnology company. Dr. Seyedin holds a B.S. in Chemistry from the University of Wisconsin, a Ph.D. in Biochemistry from the University of South Carolina and completed his post-doctoral training at the University of California - Berkeley.

www.isotech.com